User profiles for Johannes Levin
Johannes LevinProfessor for Clinical Neurodegeneration, Ludwig-Maximilians-Universität München; CMO … Verified email at med.uni-muenchen.de Cited by 14429 |
Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria,
published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for …
published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for …
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
Neurofilament light chain (NfL) is a promising fluid biomarker of disease progression for
various cerebral proteopathies. Here we leverage the unique characteristics of the Dominantly …
various cerebral proteopathies. Here we leverage the unique characteristics of the Dominantly …
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease
Abstract Development of tau-based therapies for Alzheimer’s disease requires an understanding
of the timing of disease-related changes in tau. We quantified the phosphorylation state …
of the timing of disease-related changes in tau. We quantified the phosphorylation state …
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
…, NR Graff-Radford, C la Fougère, J Levin… - The Lancet …, 2018 - thelancet.com
Background Models of Alzheimer's disease propose a sequence of amyloid β (Aβ) accumulation,
hypometabolism, and structural decline that precedes the onset of clinical dementia. …
hypometabolism, and structural decline that precedes the onset of clinical dementia. …
Hough-CNN: Deep learning for segmentation of deep brain regions in MRI and ultrasound
…, C Kroll, A Plate, V Rozanski, J Maiostre, J Levin… - Computer Vision and …, 2017 - Elsevier
In this work we propose a novel approach to perform segmentation by leveraging the abstraction
capabilities of convolutional neural networks (CNNs). Our method is based on Hough …
capabilities of convolutional neural networks (CNNs). Our method is based on Hough …
[HTML][HTML] Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease
Alzheimer’s disease (AD) pathology develops many years before the onset of cognitive
symptoms. Two pathological processes—aggregation of the amyloid-β (Aβ) peptide into plaques …
symptoms. Two pathological processes—aggregation of the amyloid-β (Aβ) peptide into plaques …
[HTML][HTML] Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease
J Wagner, S Ryazanov, A Leonov, J Levin, S Shi… - Acta …, 2013 - Springer
In neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD)
and prion diseases, deposits of aggregated disease-specific proteins are found. Oligomeric …
and prion diseases, deposits of aggregated disease-specific proteins are found. Oligomeric …
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases
…, K Buerger, R Perneczky, J Levin… - Science translational …, 2021 - science.org
2-Deoxy-2-[ 18 F]fluoro-d-glucose positron emission tomography (FDG-PET) is widely used
to study cerebral glucose metabolism. Here, we investigated whether the FDG-PET signal is …
to study cerebral glucose metabolism. Here, we investigated whether the FDG-PET signal is …
Anti-amyloid antibody therapies in Alzheimer's disease
After years of failed attempts to develop a disease-modifying therapy for Alzheimer’s disease,
consistent evidence in support of clinical efficacy was finally presented for a monoclonal …
consistent evidence in support of clinical efficacy was finally presented for a monoclonal …
[HTML][HTML] Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
Aggregation of alpha-synuclein (αS) into oligomers is critically involved in the pathogenesis
of Parkinson’s disease (PD). Using confocal single-molecule fluorescence spectroscopy, we …
of Parkinson’s disease (PD). Using confocal single-molecule fluorescence spectroscopy, we …